Literature DB >> 21086172

Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli.

Zhihua Liu1, Tongyi Shen, Peng Zhang, Yanlei Ma, Huanlong Qin.   

Abstract

Lactobacillus plantarum (LP) has previously been used for the treatment and prevention of intestinal disorders and disease. However, the role of the LP surface layer adhesive protein (SLAP) in inhibition of epithelial cell disruption is not fully understood. The aim of the present study was to investigate the protective effects of purified SLAP on Caco-2 cells infected with enteropathogenic Escherichia coli (EPEC). The role of ERK in LP-mediated inhibition of tight junction (TJ) injury was also evaluated in order to determine the molecular mechanisms underlying the protective effects of LP in epithelial cells. SLAP was extracted and purified from LP cells using a porcine stomach mucin-Sepharose 4B column. SLAP-mediated inhibition of bacterial adhesion was measured using a competition-based adhesion assay. Expression of TJ-associated proteins, maintenance of TJ structure, and levels of extracellular signal regulated kinase (ERK) and ERK phosphorylation were assessed in SLAP-treated cells by a combination of real-time PCR, western blotting, and immunofluorescence microscopy. Cell permeability was analyzed by measurement of trans-epithelial electrical resistance (TER) and dextran permeability. The effect of SLAP on levels of apoptosis in epithelial cells was assessed by flow cytometry. Results from these experiments revealed that treatment with SLAP decreased the level of adhesion of EPEC to Caco-2 cells. SLAP treatment also enhanced expression of TJ proteins at both the mRNA and protein levels and affected F-actin distribution. Although ERK levels remained unchanged, ERK phosphorylation was increased by SLAP treatment. Caco-2 cells treated with SLAP exhibited increased TER and decreased macromolecular permeability, which was accompanied by a decrease in the level of apoptosis. Together, these results suggest that LP-produced SLAP protects intestinal epithelial cells from EPEC-induced injury, likely through a mechanism involving ERK activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086172     DOI: 10.1007/s11033-010-0457-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  44 in total

Review 1.  The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.

Authors:  Kevin P Rioux; Karen L Madsen; Richard N Fedorak
Journal:  Gastroenterol Clin North Am       Date:  2005-09       Impact factor: 3.806

2.  Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability.

Authors:  Zhihua Liu; Peng Zhang; Yanlei Ma; Hongqi Chen; Yukun Zhou; Ming Zhang; Zhaoxin Chu; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2010-06-23       Impact factor: 2.316

Review 3.  Tight junctions and the molecular basis for regulation of paracellular permeability.

Authors:  J M Anderson; C M Van Itallie
Journal:  Am J Physiol       Date:  1995-10

4.  The motogenic effects of cyclic mechanical strain on intestinal epithelial monolayer wound closure are matrix dependent.

Authors:  Jianhu Zhang; Cheri R Owen; Matthew A Sanders; Jerrold R Turner; Marc D Basson
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

5.  Inhibition of the adherence of Escherichia coli strains to basement membrane by Lactobacillus crispatus expressing an S-layer.

Authors:  M Horie; A Ishiyama; Y Fujihira-Ueki; J Sillanpää; T K Korhonen; T Toba
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

6.  Repetitive deformation activates focal adhesion kinase and ERK mitogenic signals in human Caco-2 intestinal epithelial cells through Src and Rac1.

Authors:  Lakshmi S Chaturvedi; H Michael Marsh; Xun Shang; Yi Zheng; Marc D Basson
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

7.  The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939.

Authors:  Zhi-Hua Liu; Yan-Ping He; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2009-09-13       Impact factor: 2.316

8.  Repetitive deformation activates Src-independent FAK-dependent ERK motogenic signals in human Caco-2 intestinal epithelial cells.

Authors:  Lakshmi S Chaturvedi; Christopher P Gayer; Harold M Marsh; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-09       Impact factor: 4.249

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins.

Authors:  Dominique Granato; Gabriela E Bergonzelli; Raymond David Pridmore; Laure Marvin; Martine Rouvet; Irène E Corthésy-Theulaz
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  19 in total

Review 1.  Kefir: a multifaceted fermented dairy product.

Authors:  Barbara Nielsen; G Candan Gürakan; Gülhan Unlü
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

Review 2.  Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center.

Authors:  Zhi-Hua Liu; Liang Kang; Jian-Ping Wang
Journal:  Mol Biol Rep       Date:  2014-09-04       Impact factor: 2.316

3.  Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection.

Authors:  Zhihua Liu; Yanlei Ma; Mary Pat Moyer; Peng Zhang; Chenzhang Shi; Huanlong Qin
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

4.  Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice.

Authors:  Chen-Zhang Shi; Hong-Qi Chen; Yong Liang; Yang Xia; Yong-Zhi Yang; Jun Yang; Jun-Dong Zhang; Shu-Hai Wang; Jing Liu; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Comparative study on factors influencing the codon and amino acid usage in Lactobacillus sakei 23K and 13 other lactobacilli.

Authors:  Kinshuk Chandra Nayak
Journal:  Mol Biol Rep       Date:  2011-05-07       Impact factor: 2.316

6.  Effects of recombinant human intestinal trefoil factor on trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  Jin Li; Rui Zhou; Wen-Cheng He; Bing Xia
Journal:  Mol Biol Rep       Date:  2010-12-12       Impact factor: 2.316

Review 7.  Emerging role of protein modification in inflammatory bowel disease.

Authors:  Gaoying Wang; Jintao Yuan; Ji Luo; Dickson Kofi Wiredu Ocansey; Xu Zhang; Hui Qian; Wenrong Xu; Fei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

8.  Early supplementation with Lactobacillus plantarum in liquid diet modulates intestinal innate immunity through toll-like receptor 4-mediated mitogen-activated protein kinase signaling pathways in young piglets challenged with Escherichia coli K88.

Authors:  Kuanmin M Yang; Cui Zhu; Li Wang; Shuting T Cao; Xuefen F Yang; Kaiguo G Gao; Zongyong Y Jiang
Journal:  J Anim Sci       Date:  2021-06-01       Impact factor: 3.159

9.  Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro.

Authors:  Ok Kyung Koo; Mary Anne Roshni Amalaradjou; Arun K Bhunia
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Effects of Paeonol and Gastroretention Tablets of Paeonol on Experimental Gastric Ulcers and Intestinal Flora in Rats.

Authors:  Yilin Guo; Yaoyao Du; Lu Xie; Yiqiong Pu; Jianlong Yuan; Zhicheng Wang; Tong Zhang; Bing Wang
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.